Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000583:Amikacin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000008:administration & dosage; D002991:Clofazimine / Q000008:administration & dosage / Q000627:therapeutic use*; D003523:Cycloserine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D047029:Lactams, Macrocyclic; D009164:Mycobacterium Infections / Q000188:drug therapy*; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy* / Q000209:etiology; D009162:Mycobacterium avium; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D047029:Lactams, Macrocyclic; D002939:Ciprofloxacin; D000583:Amikacin; D003523:Cycloserine; D002991:Clofazimine; D007538:Isoniazid